Recro Pharma, Inc. Insider Trading for May 2018

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Recro Pharma, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in Recro Pharma, Inc. for May 2018.

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 24 2018	REPH	Recro Pharma, Inc.	Broadfin Healthcare Master Fun ...	10% Owner	Sell	S	5.51	25,000	137,750	2,048,025	2.1 M to 2 M (-1.21 %)
May 24 2018	REPH	Recro Pharma, Inc.	Broadfin Healthcare Master Fun ...	10% Owner	Sell	S	5.65	50,000	282,500	2,073,025	2.1 M to 2.1 M (-2.36 %)
May 24 2018	REPH	Recro Pharma, Inc.	Broadfin Healthcare Master Fun ...	10% Owner	Sell	S	6.00	45,700	274,200	2,123,025	2.2 M to 2.1 M (-2.11 %)
May 24 2018	REPH	Recro Pharma, Inc.	Broadfin Healthcare Master Fun ...	10% Owner	Sell	S	5.99	38,000	227,620	2,168,725	2.2 M to 2.2 M (-1.72 %)
May 24 2018	REPH	Recro Pharma, Inc.	Broadfin Healthcare Master Fun ...	10% Owner	Sell	S	5.84	29,300	171,112	2,206,725	2.2 M to 2.2 M (-1.31 %)
May 14 2018	REPH	Recro Pharma, Inc.	Ashton William	Director	Option Exercise	M	0.00	13,274	0	0
May 14 2018	REPH	Recro Pharma, Inc.	Ashton William	Director	Buy	M	0.00	13,274	0	19,457	6.2 K to 19.5 K (+214.69 %)
May 14 2018	REPH	Recro Pharma, Inc.	Flynn Karen	Director	Option Exercise	M	0.00	13,274	0	0
May 14 2018	REPH	Recro Pharma, Inc.	Flynn Karen	Director	Buy	M	0.00	13,274	0	20,257	7 K to 20.3 K (+190.09 %)
May 14 2018	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Option Exercise	M	0.00	13,274	0	0
May 14 2018	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Buy	M	0.00	13,274	0	26,457	13.2 K to 26.5 K (+100.69 %)
May 14 2018	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Option Exercise	M	0.00	13,274	0	0
May 14 2018	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Buy	M	0.00	13,274	0	19,457	6.2 K to 19.5 K (+214.69 %)
May 14 2018	REPH	Recro Pharma, Inc.	ALTOMARI ALFRED	Director	Option Exercise	M	0.00	13,274	0	0
May 14 2018	REPH	Recro Pharma, Inc.	ALTOMARI ALFRED	Director	Option Exercise	M	0.00	13,274	0	0
May 14 2018	REPH	Recro Pharma, Inc.	ALTOMARI ALFRED	Director	Buy	M	0.00	13,274	0	20,957	7.7 K to 21 K (+172.77 %)
May 14 2018	REPH	Recro Pharma, Inc.	ALTOMARI ALFRED	Director	Buy	M	0.00	13,274	0	20,957	7.7 K to 21 K (+172.77 %)
May 14 2018	REPH	Recro Pharma, Inc.	Reasons Bryan M.	Director	Option Exercise	M	0.00	8,849	0	0
May 14 2018	REPH	Recro Pharma, Inc.	Reasons Bryan M.	Director	Option Exercise	M	0.00	8,849	0	0
May 14 2018	REPH	Recro Pharma, Inc.	Reasons Bryan M.	Director	Buy	M	0.00	8,849	0	15,032	6.2 K to 15 K (+143.12 %)
May 14 2018	REPH	Recro Pharma, Inc.	Reasons Bryan M.	Director	Buy	M	0.00	8,849	0	15,032	6.2 K to 15 K (+143.12 %)
May 08 2018	REPH	Recro Pharma, Inc.	ALTOMARI ALFRED	Director	Option Exercise	A	11.32	5,742	64,999	5,742
May 08 2018	REPH	Recro Pharma, Inc.	ALTOMARI ALFRED	Director	Grant	A	0.00	6,183	0	7,683	1.5 K to 7.7 K (+412.20 %)
May 08 2018	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Option Exercise	A	11.32	5,742	64,999	5,742
May 08 2018	REPH	Recro Pharma, Inc.	CHURCHILL WINSTON J	Director	Grant	A	0.00	6,183	0	6,183	0 to 6.2 K
May 08 2018	REPH	Recro Pharma, Inc.	Flynn Karen	Director	Option Exercise	A	11.32	5,742	64,999	5,742
May 08 2018	REPH	Recro Pharma, Inc.	Flynn Karen	Director	Grant	A	0.00	6,183	0	6,983	800 to 7 K (+772.88 %)
May 08 2018	REPH	Recro Pharma, Inc.	Ashton William	Director	Option Exercise	A	11.32	5,742	64,999	5,742
May 08 2018	REPH	Recro Pharma, Inc.	Ashton William	Director	Grant	A	0.00	6,183	0	6,183	0 to 6.2 K
May 08 2018	REPH	Recro Pharma, Inc.	Reasons Bryan M.	Director	Option Exercise	A	11.32	5,742	64,999	5,742
May 08 2018	REPH	Recro Pharma, Inc.	Reasons Bryan M.	Director	Grant	A	0.00	6,183	0	6,183	0 to 6.2 K
May 08 2018	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Option Exercise	A	11.32	5,742	64,999	5,742
May 08 2018	REPH	Recro Pharma, Inc.	Weisman Wayne	Director	Grant	A	0.00	6,183	0	13,183	7 K to 13.2 K (+88.33 %)
May 08 2018	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Option Exercise	A	11.32	5,742	64,999	5,742
May 08 2018	REPH	Recro Pharma, Inc.	Berelowitz Michael	Director	Grant	A	0.00	6,183	0	6,183	0 to 6.2 K